Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Erasca Inc. Common Stock (ERAS) vs iShares Core S&P 500 ETF (IVV) Price & Performance

Erasca Inc. Common StockTrade
iShares Core S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Erasca Inc. Common Stock vs iShares Core S&P 500 ETF — how do they compare? Erasca Inc. Common Stock trades at $15.57 (market cap $4.95B), while iShares Core S&P 500 ETF trades at $781 (market cap $899.63B). The key difference: iShares Core S&P 500 ETF is far larger — about 181.7× Erasca Inc. Common Stock's market cap, and iShares Core S&P 500 ETF is trading nearer its 52-week high, Erasca Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and iShares Core S&P 500 ETF for 46 Days on average.

ERASIVV
Market Cap
$4.95B$899.63B
Volume
3,834,6893,643,926
Sector
HealthBroad Market / Factor
52-Week High
$22.47$782.58
52-Week Low
$2.20$634.93
Typical Hold Time
0 Days46 Days
Enterprise Value
$4.72B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Erasca Inc. Common Stock

No Aura AI signal available yet.

iShares Core S&P 500 ETF

IVV, tracking the S&P 500, trades at $780.60, down 0.25% on the day. Technical indicators show a bullish trend with moving averages strongly positive, though RSI suggests potential overbought conditions near-term. The ETF remains a core holding for broad US equity exposure, with recent news highlighting strong corporate earnings growth expectations of 35% for 2026. Market sentiment is mixed as valuations attract scrutiny despite index strength.

Outlook remains constructive given the S&P 500's earnings momentum and historical seasonal trends favoring year-end rallies. Key risks include potential profit growth deceleration to 15% in 2027 and concentration in top holdings. The ETF offers diversified exposure to large-cap US equities, with the current level near pivot point support providing a strategic entry zone for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ERAS
100% Buy0% Sell
Avg holding period · 0 Days
IVV
90% Buy10% Sell
Avg holding period · 46 Days

Top news

Latest headlines on both assets

About Erasca Inc. Common Stock

Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.

Read more on ERAS →

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.

Read more on IVV →